Matysiak, Joanna et al. published new experimental results with the assistance of cas: 5805-39-0

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Formula: C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Formula: C13H11N3In 2018, Matysiak, Joanna;Skrzypek, Alicja;Glaszcz, Urszula;Matwijczuk, Arkadiusz;Senczyna, Bogdan;Wietrzyk, Joanna;Krajewska-Kulak, Elzbieta;Niewiadomy, Andrzej published 《Synthesis and biological activity of novel benzoazoles, benzoazines and other analogs functionalized by 2,4-dihydroxyphenyl moiety》. 《Research on Chemical Intermediates》published the findings. The article contains the following contents:

Novel benzoazoles, benzoazines, benzothiazoles, benzothiazines and other related compounds possessing a 2,4-dihydroxyphenyl moiety were prepared The compounds were obtained by the reaction of sulfinylbis[(2,4-dihydroxyphenyl)methanethione]s with the appropriate heterocyclic amines or hydrazines. Human cancer lines, Candida species and phytopathogenic fungi were used for the evaluation of biol. potency of compounds Addnl., drug-like properties were estimated in silico. The experimental procedure involved many compounds, such as 2-(1H-Benzo[d]imidazol-2-yl)aniline (cas: 5805-39-0) .

2-(1H-Benzo[d]imidazol-2-yl)aniline(cas:5805-39-0 Formula: C13H11N3) is a chemical reagent used in the synthesis of small molecule inhibitors targeting ubiquitin-like domains for treatments of diseases caused by the cellular accumulation of damaged proteins.

Reference:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem